Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 119, 67-75
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2014/18938-8, 2014/50867-3, 2014/50891-1)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (454234/2014-7, 455953/2014-7)
This publication has 75 references indexed in Scilit:
- Schizophrenia shows a unique metabolomics signature in plasmaTranslational Psychiatry, 2012
- Potential metabolite markers of schizophreniaMolecular Psychiatry, 2011
- How Genes and Environmental Factors Determine the Different Neurodevelopmental Trajectories of Schizophrenia and Bipolar DisorderSchizophrenia Bulletin, 2011
- Metabolome in schizophrenia and other psychotic disorders: a general population-based studyGenome Medicine, 2011
- Atypical Antipsychotics Rapidly and Inappropriately Switch Peripheral Fuel Utilization to Lipids, Impairing Metabolic Flexibility in RodentsSchizophrenia Bulletin, 2010
- BioMagResBankNucleic Acids Research, 2007
- HMDB: the Human Metabolome DatabaseNucleic Acids Research, 2007
- Isovaleric acidemia: New aspects of genetic and phenotypic heterogeneityAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2006
- The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patientsLife Sciences, 1991
- A Rating Scale for Mania: Reliability, Validity and SensitivityThe British Journal of Psychiatry, 1978